# US 2020/0289825 A1 · Actuated Electrode Lead in Minimally Invasive Cochlear Implant Surgery

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2020/0289825 A1
- Document ID: US20200289825A1
- Status: Published application
- Kind: A1
- Application number: 16/338,777
- Filed: 2017-11-01
- Published: 2020-09-17
- Earliest claimed: 2016-11-01
- Assignees: MED-EL Elektromedizinische Geraete GmbH
- Applicants: MED-EL Elektromedizinische Geraete GmbH
- Inventors: Max Frölich; Daniel Schurzig
- Web page: https://patentgrep.com/patent/US20200289825A1

## CPC

- C11D 3/42: Brightening agents {; Blueing agents}
- A61N 1/0541: {Cochlear electrodes}
- A61N 1/36038: {Cochlear stimulation}
- A61N 1/36139: {with automatic adjustment}
- A61N 1/372: Arrangements in connection with the implantation of stimulators
- A61N 1/3752: {Details of casing-lead connections}
- C09B 9/02: of anthracene dyes
- C09B 11/12: without any OH group bound to an aryl nucleus
- C09B 57/00: Other synthetic dyes of known constitution
- C09B 69/00: Dyes not provided for by a single group of this subclass
- C09B 69/101: {containing an anthracene dye}
- C09B 69/103: {containing a diaryl- or triarylmethane dye}
- C09B 69/109: {containing other specific dyes}
- C11D 3/0084: {Antioxidants; Free-radical scavengers}
- C11D 3/187: {aromatic}
- C11D 3/20: containing oxygen {(C11D3/162, C11D3/164, C11D3/166, C11D3/168 take precedence)}
- C11D 3/26: containing nitrogen {(C11D3/162, C11D3/164, C11D3/166, C11D3/168 take precedence)}
- C11D 3/40: Dyes {; Pigments}
- D06L 4/60: Optical bleaching or brightening
- D06L 4/657: combined with other treatments, e.g. finishing, bleaching, softening, dyeing or pigment printing
- D06P 1/0012: {Effecting dyeing to obtain luminescent or phosphorescent dyeings}
- C11D: DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- A61N: ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY (measurement of bioelectric currents A61B; surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body A61B18/00; anaesthetic apparatus in general A61M; incandescent lamps H01K; infrared radiators for heating H05B)
- C09B: ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES {, e.g. PIGMENTS}; MORDANTS; LAKES (fermentation or enzyme using processes to synthesise a desired chemical compound C12P)
- D06L: DRY-CLEANING, WASHING OR BLEACHING FIBRES, FILAMENTS, THREADS, YARNS, FABRICS, FEATHERS OR MADE-UP FIBROUS GOODS; BLEACHING LEATHER OR FURS
- D06P: DYEING OR PRINTING TEXTILES; DYEING LEATHER, FURS OR SOLID MACROMOLECULAR SUBSTANCES IN ANY FORM

## Abstract

An implantable electrode arrangement for a cochlear implant system is described. An electrode lead contains a lead structure control element configured to control a lead shape of the electrode lead between an insertion state wherein the electrode lead within a mastoid tunnel has a longitudinal lead axis lying entirely along the tunnel axis, and a post-insertion state wherein a facial recess portion of the electrode lead fitting within a limited diameter portion of the mastoid tunnel associated with a facial recess portion of the mastoid bone has a longitudinal lead axis along the tunnel axis, and a storage portion of the electrode lead fitting within an enlarged diameter portion of the mastoid tunnel lateral to the facial recess portion has a longitudinal lead axis coiled in a helical shape radially around the tunnel axis.

## Claims

### Claim 1

An implantable electrode arrangement for a cochlear implant system comprising:
an electrode lead configured for carrying one or more cochlear stimulation signals and configured to fit through a mastoid tunnel extending along a longitudinal tunnel axis from a lateral outer surface of patient mastoid bone through the patient mastoid bone into the middle ear;
an electrode array connected to a distal end of the electrode lead and configured for insertion into a patient cochlea, wherein the electrode array has an outer surface with a plurality of stimulation contacts configured for applying the cochlear stimulation signals to target neural tissue within the patient cochlea; and
a lead structure control element within the electrode lead configured to control a lead shape of the electrode lead between two stable states:
an insertion state wherein the electrode lead within the mastoid tunnel has a longitudinal lead axis lying entirely along the tunnel axis; and
a post-insertion state wherein:
a facial recess portion of the electrode lead fitting within a limited diameter portion of the mastoid tunnel associated with a facial recess portion of the mastoid bone has a longitudinal lead axis along the tunnel axis, and
a storage portion of the electrode lead fitting within an enlarged diameter portion of the mastoid tunnel lateral to the facial recess portion has a longitudinal lead axis coiled in a helical shape radially around the tunnel axis.

### Claim 2 (depends on 1)

The electrode arrangement according to claim 1, wherein the lead structure control element comprises one or more shape memory alloy elements to control lead shape.

### Claim 3 (depends on 1)

The electrode arrangement according to claim 1, wherein the lead structure control element is configured to control lead shape as a function of temperature.

### Claim 4 (depends on 3)

The electrode arrangement according to claim 3, wherein the lead structure control element includes one or more lead heating elements configured for heating the electrode lead.

### Claim 5 (depends on 1)

The electrode arrangement according to claim 1, further comprising:
a lead stopper connected to the electrode lead and configured to securely fit into the mastoid tunnel from the middle ear so as to resist rotation of electrode array when the lead structure control element controls the lead shape into the post-insertion state.

### Claim 6 (depends on 5)

The electrode arrangement according to claim 5, wherein the lead stopper is structurally integrated into the electrode lead.

### Claim 7 (depends on 5)

The electrode arrangement according to claim 5, wherein the lead stopper is a structurally separate element securely attached to the electrode lead.

### Claim 8 (depends on 1, 2, 3, 4, 5, 6, 7)

A cochlear implant system having an electrode arrangement according to any of claims 1-7.

### Claim 9

A method of implanting a cochlear implant electrode in a patient, the method comprising:
preparing an outer mastoid tunnel extending along a longitudinal tunnel axis from a lateral outer surface of a patient mastoid bone through the mastoid bone towards a facial recess region of the patient mastoid bone, wherein the outer mastoid tunnel is characterized by an outer tunnel diameter;
preparing an inner mastoid tunnel along the tunnel axis through the facial recess region of the mastoid bone into the middle ear, wherein the inner mastoid tunnel is characterized by an inner tunnel diameter less than the outer tunnel diameter;
preparing a cochlear opening in an outer surface of a patient cochlea at a point along the tunnel axis;
providing an implant electrode arrangement comprising an electrode lead configured for carrying one or more cochlear stimulation signals and having a distal end connected to an electrode array with an outer surface having a plurality of stimulation contacts configured for applying the cochlear stimulation signals to target neural tissue within the patient cochlea, wherein the electrode lead further comprises a lead structure control element configured to control lead shape;
fitting the electrode array through the outer mastoid tunnel, the inner mastoid tunnel, the middle ear, and the cochlear opening to implant the electrode array into the patient cochlea, wherein the lead structure control element operates to maintain the electrode lead enclosed within the outer mastoid tunnel and the inner mastoid tunnel in an insertion shape lying entirely along a longitudinal lead axis extending along the tunnel axis; and
operating the lead structure control element to modify lead shape of the electrode lead into a post-insertion shape wherein:
a facial recess portion of the electrode lead fitting within the inner mastoid tunnel has a longitudinal lead axis along the tunnel axis, and
a storage portion of the electrode lead fitting within the outer mastoid tunnel has a longitudinal lead axis coiled in a helical shape radially around the tunnel axis.

### Claim 10 (depends on 9)

The method according to claim 9, wherein the lead structure control element comprises one or more shape memory alloy elements to control lead shape.

### Claim 11 (depends on 9)

The method according to claim 9, wherein the lead structure control element is configured to control lead shape as a function of temperature.

### Claim 12 (depends on 11)

The method according to claim 11, wherein the lead structure control element includes one or more lead heating elements configured for heating the electrode lead.

### Claim 13 (depends on 9)

The method according to claim 9, further comprising:
securely fitting a lead stopper connected to the electrode lead into the inner mastoid tunnel from the middle ear so as to resist rotation of electrode array when the lead structure control element operates to modify the lead shape into the post-insertion state.

### Claim 14 (depends on 13)

The method according to claim 13, wherein the lead stopper is structurally integrated into the electrode lead.

### Claim 15 (depends on 13)

The method according to claim 13, wherein the lead stopper is a structurally separate element securely attached to the electrode lead.
